THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Cambridge biotech company sells for $1.6b

After British deal, TKT's CEO quits

By Jeffrey Krasner
Globe Staff / April 22, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

One of the region's leading biotechnology companies said yesterday that it would be acquired by a British drug company for $1.6 billion, a decision that prompted the Cambridge company's chief executive to resign in protest. (Full article: 1109 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass

Boston.com top stories on Twitter

    waiting for twitterWaiting for Twitter to feed in the latest...